RBC's Bullish Neurologist Survey Leads To A $108 Price Target On Sarepta Therapeutics
September 28, 2016 at 08:45 AM EDT
A recent neurologist survey and the latest call with DMD KOLs support a bullish stance on the commercial prospects of Sarepta ...